Mangeet Kaur Bouns: Page 15
Latest: Page 15
1 Biotech Stock to Double Down on in Q4
Leading drug maker Amgen (AMGN) delivered impressive second-quarter results. The company is well-positioned for solid long-term growth, driven by its diversified and growing product portfolio, rising demand from a rapidly...
Ready to Make Passive Income? Consider Buying This Health Care Stock
Leading biopharmaceutical company Bristol-Myers Squibb (BMY) reported solid financials in the last quarter. Its diversified product portfolio and inelastic demand for such products brighten its near-term prospects. Moreover, the company's...
1 Stock That's Too Good to Pass up Right Now
Shares of renowned Oil & Gas company Energy Transfer (ET) have gained more than 35% year-to-date despite the broader market's collapse. Given its solid second-quarter results, the company has increased...
This 1 Stock Could Be Your Best Bear Market Buy
Renowned food and drug retailer Albertsons (ACI) reported impressive second-quarter financials and is well-positioned to witness continued growth in the upcoming quarters, driven by steady product demand. Moreover, Wall Street...
Is This Former Meme Stock Now a Buy?
Shares of cybersecurity company Blackberry (BB) have plummeted more than 50% year-to-date amid heightened market volatility. Analysts expect the company's revenue and earnings to decline for the fiscal year. Despite...
Rising Inflation Keeps Pushing This EV Stock Further off the Road
Electric Vehicle (EV) maker Lucid Group (LCID) failed to translate its top-line growth to bottom-line improvement in the second quarter of fiscal 2022. While the company mentioned strong demand for...
